Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Medulloblastoma × Triiodothyronine × Clear all

Phase

Phase 2 1 Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Medulloblastoma 1

Interventions

Temozolomide 6 Radiotherapy 4 Irinotecan 3 Nivolumab 2 Carboplatin 2 sodium thiosulfate 1 silmitasertib 1 poly ICLC 1 plerixafor 1 lutetium Lu 177 dotatate 1 etoposide phosphate 1 entrectinib 1 dinutuximab 1 bempegaldesleukin 1 adavosertib 1 abemaciclib 1 Vincristine 1 Vascular Endothelial Growth Factor A 1 Vaccines 1 Triiodothyronine 1 TPI-287 1 Surgical Procedures, Operative 1 Radiation 1 Peripheral Blood Stem Cell Transplantation 1 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 1 Microarray Analysis 1 Melphalan 1 Mannitol 1 Maintenance Chemotherapy 1 Magnetic Resonance Spectroscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07346157 2026-01-16

PNOC044

University of California, San Francisco

Phase 1/2 Not yet recruiting

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡